LED Light‐Induced Modulation of the Anticancer Activity of a [(2‐(6‐Bromopyridin‐2‐yl)‐1 H ‐benzo[d]imidazol‐6‐yl)(phenyl)methanone]‐Based Iridium(III) Complex
Chemistry – An Asian Journal · 2026-11 · 21 (21)
DOI: 10.1002/asia.71034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – An Asian Journal, online erschienen am 30.10.2026. Verfasst von Utpal Das und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore, Tamil Nadu, India. Hauptthemen laut MEDLINE: Iridium, Antineoplastic Agents, Coordination Complexes, Light. Die Arbeit nennt 28 Literaturangaben. Gefördert von: DST-SERB CRG project.
Abstract (Originalsprache)
Metal complexes are emerging as powerful agents in light‐activated cancer therapy, a cutting‐edge therapeutic strategy for combating cancer and other serious diseases. Among them, iridium (Ir)‐based photosensitizers have recently gained significant attention, driving innovation in photo‐activated cancer therapy and opening new avenues for targeted treatment. Building on this momentum, we have designed a novel benzimidazole‐based iridium complex, [LIr] , which demonstrates remarkable potential as a phototherapeutic agent. Upon activation with a direct light source from a 40 W white LED (400−700 nm), with a fixed distance of 15 cm between the light source and the samples maintained throughout all the experiments, [LIr] exhibits potent catalytic activity, efficiently oxidizing key cellular antioxidants: converting glutathione (GSH) to glutathione disulfide (GSSG), NADH to NAD + , and NADPH to NADP + . This redox disruption compromises cancer cell defenses and enhances therapeutic efficacy. In addition, light activation of complex [LIr] generates a burst of reactive oxygen species (ROS), including the highly cytotoxic singlet oxygen, with a notable singlet oxygen quantum yield. This multifaceted reactivity not only disrupts cellular redox balance but also induces oxidative stress in targeted cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
- Bioinspired Design Lab, School of BioSciences and Technology (SBST), Vellore Institute of Technology, Vellore, Tamil Nadu, India.
- Stem Cells and Regenerative Medicine Centre, Yenepoya Research Centre, Yenepoya (Deemed to Be University), Mangalore, Karnataka, India.
ORCID-Profile: Pavan Gutti, Rishav Das, Shanooja Shanavas, Bipasha Bose, Priyankar Paira
Förderung
- DST-SERB CRG project
Zitieren
APA
Das, U., Gutti, P., Das, R., Shanavas, S., Mishra, D., P, S. S., Bose, B., & Paira, P. (2026). LED Light‐Induced Modulation of the Anticancer Activity of a [(2‐(6‐Bromopyridin‐2‐yl)‐1 H ‐benzo[d]imidazol‐6‐yl)(phenyl)methanone]‐Based Iridium(III) Complex. Chemistry – An Asian Journal, 21(21). https://doi.org/10.1002/asia.71034
Vancouver
Das U, Gutti P, Das R, Shanavas S, Mishra D, P SS, et al. LED Light‐Induced Modulation of the Anticancer Activity of a [(2‐(6‐Bromopyridin‐2‐yl)‐1 H ‐benzo[d]imidazol‐6‐yl)(phenyl)methanone]‐Based Iridium(III) Complex. Chemistry – An Asian Journal. 2026;21(21). doi:10.1002/asia.71034
BibTeX
@article{Das2026,
author = {Das, Utpal and Gutti, Pavan and Das, Rishav and Shanavas, Shanooja and Mishra, Debasish and P, Sudheer Shenoy and Bose, Bipasha and Paira, Priyankar},
title = {LED Light‐Induced Modulation of the Anticancer Activity of a [(2‐(6‐Bromopyridin‐2‐yl)‐1 H ‐benzo[d]imidazol‐6‐yl)(phenyl)methanone]‐Based Iridium(III) Complex},
journal = {Chemistry – An Asian Journal},
year = {2026},
volume = {21},
number = {21},
doi = {10.1002/asia.71034}
}
EUVIMED